{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:59:45Z","timestamp":1787169585334,"version":"build-2736575974"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T00:00:00Z","timestamp":1691712000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Addictive Behaviors Reports"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.abrep.2023.100513","type":"journal-article","created":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T23:44:02Z","timestamp":1691797442000},"page":"100513","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Associations between individual hallucinogens and hallucinogen misuse among U.S. Adults who recently initiated hallucinogen use"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2426-310X","authenticated-orcid":false,"given":"Grant","family":"Jones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6945-6810","authenticated-orcid":false,"given":"Felipe","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.abrep.2023.100513_b0020","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1037\/1064-1297.2.3.244","article-title":"Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: Basic findings from the National Comorbidity Survey","volume":"2","author":"Anthony","year":"1994","journal-title":"Experimental and Clinical Psychopharmacology"},{"key":"10.1016\/j.abrep.2023.100513_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2021.173129","article-title":"Use and abuse of dissociative and psychedelic drugs in adolescence","volume":"203","author":"Bates","year":"2021","journal-title":"Pharmacology Biochemistry and Behavior"},{"issue":"1","key":"10.1016\/j.abrep.2023.100513_b0030","first-page":"9","article-title":"Phencyclidine Intoxication and Adverse Effects: A Clinical and Pharmacological Review of an Illicit Drug","volume":"8","author":"Bey","year":"2007","journal-title":"The California Journal of Emergency Medicine"},{"key":"10.1016\/j.abrep.2023.100513_b0040","series-title":"Emergency Department Visits Involving Phencyclidine (PCP)","author":"Bush","year":"2013"},{"issue":"6","key":"10.1016\/j.abrep.2023.100513_b0050","doi-asserted-by":"crossref","first-page":"677","DOI":"10.4088\/JCP.v66n0602","article-title":"Prevalence, correlates, and comorbidity of DSM-IV antisocial personality syndromes and alcohol and specific drug use disorders in the United States: Results from the national epidemiologic survey on alcohol and related conditions","volume":"66","author":"Compton","year":"2005","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"2","key":"10.1016\/j.abrep.2023.100513_b0065","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1080\/10550887.2013.797279","article-title":"The Association Between Phencyclidine Use and Partner Violence: An Initial Examination","volume":"32","author":"Crane","year":"2013","journal-title":"Journal of Addictive Diseases"},{"key":"10.1016\/j.abrep.2023.100513_b0080","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.pnpbp.2015.03.011","article-title":"MDMA-assisted therapy: A new treatment model for social anxiety in autistic adults","volume":"64","author":"Danforth","year":"2016","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"issue":"3","key":"10.1016\/j.abrep.2023.100513_b0085","doi-asserted-by":"crossref","first-page":"184","DOI":"10.2174\/1874467211666181010154139","article-title":"Pharmacokinetic and Pharmacodynamic Aspects of Peyote and Mescaline: Clinical and Forensic Repercussions","volume":"12","author":"Dinis-Oliveira","year":"2019","journal-title":"Current Molecular Pharmacology"},{"issue":"4","key":"10.1016\/j.abrep.2023.100513_b0095","first-page":"299","article-title":"\u2018Rushing behind the wheel\u2019: Investigating the prevalence of \u2018drug driving\u2019 among club and rave patrons in Melbourne, Australia","volume":"13","author":"Duff","year":"2006","journal-title":"Drugs: Education, Prevention and Policy"},{"issue":"8","key":"10.1016\/j.abrep.2023.100513_b0100","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1111\/j.1530-0277.1996.tb01152.x","article-title":"DSM-IV, DSM-III-R, and ICD-10 alcohol and drug abuse\/harmful use and dependence, United States, 1992: A nosological comparison","volume":"20","author":"Grant","year":"1996","journal-title":"Alcoholism, Clinical and Experimental Research"},{"issue":"3","key":"10.1016\/j.abrep.2023.100513_b0105","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/14659890701374703","article-title":"Bad bars: A review of risk factors","volume":"12","author":"Green","year":"2007","journal-title":"Journal of Substance Use"},{"key":"10.1016\/j.abrep.2023.100513_b0145","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.neuropharm.2018.05.012","article-title":"The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act","volume":"142","author":"Johnson","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.abrep.2023.100513_b0150","unstructured":"Journey, J. D., & Bentley, T. P. (2022). Phencyclidine Toxicity. In StatPearls. StatPearls Publishing. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK507865\/."},{"issue":"3","key":"10.1016\/j.abrep.2023.100513_b0155","doi-asserted-by":"crossref","first-page":"e2825","DOI":"10.1002\/hup.2825","article-title":"The potential role of lysergic acid diethylamide for psychological assisted therapy: A meta-analysis of randomised controlled trials in healthy volunteers","volume":"37","author":"Li","year":"2022","journal-title":"Human Psychopharmacology: Clinical and Experimental"},{"issue":"12","key":"10.1016\/j.abrep.2023.100513_b0165","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1111\/add.15987","article-title":"Adolescent and adult time trends in US hallucinogen use, 2002\u201319: Any use, and use of ecstasy","volume":"117","author":"Livne","year":"2022","journal-title":"LSD and PCP. Addiction"},{"issue":"3","key":"10.1016\/j.abrep.2023.100513_b0170","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/026988110101500310","article-title":"Former chronic methylenedioxymethamphetamine (MDMA or ecstasy) users report mild depressive symptoms","volume":"15","author":"MacInnes","year":"2001","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.abrep.2023.100513_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2021.113888","article-title":"Neurological and cognitive alterations induced by MDMA in humans","volume":"347","author":"Montgomery","year":"2022","journal-title":"Experimental Neurology"},{"issue":"9","key":"10.1016\/j.abrep.2023.100513_b0205","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1017\/S0033291707002450","article-title":"Attentional bias to incentive stimuli in frequent ketamine users","volume":"38","author":"Morgan","year":"2008","journal-title":"Psychological Medicine"},{"key":"10.1016\/j.abrep.2023.100513_b0210","doi-asserted-by":"crossref","unstructured":"Morgan, C. J., Curran, H. V., & Drugs (ISCD), I. S. C. on. (2012). Ketamine use: A review. Addiction, 107(1), 27\u201338.","DOI":"10.1111\/j.1360-0443.2011.03576.x"},{"issue":"1","key":"10.1016\/j.abrep.2023.100513_b0215","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1360-0443.2009.02761.x","article-title":"Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: A 1-year longitudinal study","volume":"105","author":"Morgan","year":"2010","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.abrep.2023.100513_b0230","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1124\/pr.115.011478","article-title":"Psychedelics","volume":"68","author":"Nichols","year":"2016","journal-title":"Pharmacological Reviews"},{"issue":"3","key":"10.1016\/j.abrep.2023.100513_b0235","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/02791072.2004.10400039","article-title":"CLUB DRUG USE AMONG MINORITY SUBSTANCE USERS IN NEW YORK CITY[dagger]","volume":"36","author":"Ompad","year":"2004","journal-title":"Journal of Psychoactive Drugs"},{"issue":"1","key":"10.1016\/j.abrep.2023.100513_b0250","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12954-022-00598-5","article-title":"A qualitative investigation exploring why dance festivals are risky environments for drug use and potential adverse outcomes","volume":"19","author":"Palamar","year":"2022","journal-title":"Harm Reduction Journal"},{"issue":"1","key":"10.1016\/j.abrep.2023.100513_b0255","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF03033898","article-title":"Comorbidity of substance abuse with other psychiatric disorders","volume":"12","author":"Palomo","year":"2007","journal-title":"Neurotoxicity Research"},{"issue":"8","key":"10.1016\/j.abrep.2023.100513_b0275","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.biopsych.2014.11.015","article-title":"Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects","volume":"78","author":"Schmid","year":"2015","journal-title":"Biological Psychiatry"},{"issue":"2","key":"10.1016\/j.abrep.2023.100513_b0285","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.drugalcdep.2006.08.008","article-title":"Who is becoming hallucinogen dependent soon after hallucinogen use starts?","volume":"87","author":"Stone","year":"2007","journal-title":"Drug and Alcohol Dependence"},{"issue":"7","key":"10.1016\/j.abrep.2023.100513_b0290","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.addbeh.2005.08.005","article-title":"Party people: Personality and MDMA use of house party visitors","volume":"31","author":"ter Bogt","year":"2006","journal-title":"Addictive Behaviors"},{"issue":"14","key":"10.1016\/j.abrep.2023.100513_b0295","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1503\/cmaj.141124","article-title":"Psychedelic medicine: A re-emerging therapeutic paradigm","volume":"187","author":"Tupper","year":"2015","journal-title":"Canadian Medical Association Journal"},{"key":"10.1016\/j.abrep.2023.100513_b0300","unstructured":"United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality. (2015). National Survey on Drug Use and Health, 2015. https:\/\/datafiles.samhsa.gov\/."},{"key":"10.1016\/j.abrep.2023.100513_b0305","unstructured":"United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality. (2016). National Survey on Drug Use and Health, 2016. https:\/\/datafiles.samhsa.gov\/."},{"key":"10.1016\/j.abrep.2023.100513_b0310","unstructured":"United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality. (2017). National Survey on Drug Use and Health, 2017. https:\/\/datafiles.samhsa.gov\/."},{"key":"10.1016\/j.abrep.2023.100513_b0315","unstructured":"United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality. (2018). National Survey on Drug Use and Health, 2018. https:\/\/datafiles.samhsa.gov\/."},{"key":"10.1016\/j.abrep.2023.100513_b0320","unstructured":"United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality. (2019). National Survey on Drug Use and Health, 2019. https:\/\/datafiles.samhsa.gov\/."},{"key":"10.1016\/j.abrep.2023.100513_b0325","unstructured":"United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality. (2020). National Survey on Drug Use and Health, 2020. https:\/\/datafiles.samhsa.gov\/."},{"issue":"1","key":"10.1016\/j.abrep.2023.100513_b0330","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/14740338.2021.1949454","article-title":"Harm related to recreational ketamine use and its relevance for the clinical use of ketamine. A systematic review and comparison study","volume":"21","author":"Van Amsterdam","year":"2022","journal-title":"Expert Opinion on Drug Safety"},{"issue":"3","key":"10.1016\/j.abrep.2023.100513_b0340","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.addbeh.2009.10.009","article-title":"An item response theory analysis of DSM-IV criteria for hallucinogen abuse and dependence in adolescents","volume":"35","author":"Wu","year":"2010","journal-title":"Addictive Behaviors"},{"issue":"5","key":"10.1016\/j.abrep.2023.100513_b0345","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1080\/10550490802269064","article-title":"Hallucinogen Use Disorders Among Adult Users of MDMA and Other Hallucinogens","volume":"17","author":"Wu","year":"2008","journal-title":"The American Journal on Addictions"},{"issue":"1\u20132","key":"10.1016\/j.abrep.2023.100513_b0350","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.drugalcdep.2009.04.014","article-title":"Hallucinogen-related disorders in a national sample of adolescents: The influence of ecstasy\/MDMA use","volume":"104","author":"Wu","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.abrep.2023.100513_b0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108071","article-title":"Trends in LSD use among US adults: 2015\u20132018","volume":"212","author":"Yockey","year":"2020","journal-title":"Drug and Alcohol Dependence"}],"container-title":["Addictive Behaviors Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352853223000354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352853223000354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T04:59:13Z","timestamp":1762491553000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352853223000354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":39,"alternative-id":["S2352853223000354"],"URL":"https:\/\/doi.org\/10.1016\/j.abrep.2023.100513","relation":{},"ISSN":["2352-8532"],"issn-type":[{"value":"2352-8532","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Associations between individual hallucinogens and hallucinogen misuse among U.S. Adults who recently initiated hallucinogen use","name":"articletitle","label":"Article Title"},{"value":"Addictive Behaviors Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abrep.2023.100513","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100513"}}